Mary Kay Unveils Groundbreaking Research During Skin of Color Society Virtual Program
Mary Kay Inc., a leader in skin care innovation for more than 56 years, continued its ongoing support of the beauty and scientific communities by presenting findings during the 2020 Skin of Color Society Symposium Virtual Program.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005633/en/
Dr. Cristi Gomez, Director, Product Safety & Environmental Toxicology, revealed new research on the science behind LumiVie, an intensive serum by Mary Kay that brightens, energizes and moisturizes skin. As urbanization increases globally, the effects of pollution on skin is a growing concern. Chronic exposure to air pollution has been correlated with visible aging—in particular, the development of pigment spots. Researchers at Mary Kay developed a skincare formulation containing botanical extracts and vitamins B3 and C that is both suitable for sensitive skin and effective at addressing skin pigment concerns. They also observed improvements in skin tone evenness, luminosity and texture.
“Our team is dedicated to conducting research and developing innovative solutions to address common skin issues that impact women and their self-confidence,” said Dr. Lucy Gildea, Chief Scientific Officer at Mary Kay. “In 2020, Mary Kay Research & Development will continue to share the latest groundbreaking discoveries with the scientific community at large.”
The Skin of Color Society Symposium Virtual Program is just the latest event Mary Kay has participated in with scientific and academic communities that reinforce the brand’s longstanding commitment to advancing skin health research and development. Every year, Mary Kay conducts hundreds of thousands of scientific tests on products and ingredients to ensure the highest standards of safety, quality and performance. Mary Kay holds more than 1,500 patents for products, technologies and packaging designs in its global portfolio. In 2018, the company announced the opening of a more than $100 million state-of-the-art manufacturing and R&D facility in Lewisville, Texas.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TX-PLANVIEW9.7.2020 16:05:11 CEST | Press release
Planview Acquires AI/ML Leader Aptage
BOEHRINGER-INGELHEIM9.7.2020 16:02:10 CEST | Press release
Perceived burden of disease is greater in younger people living with COPD, global survey reveals
TRUEBLUE9.7.2020 15:36:09 CEST | Press release
Trueblue Announces Integration with Microsoft Dynamics 365 to Enhance Customer Engagement in the Life Sciences Market
PA-BENTLEY-SYSTEMS9.7.2020 15:33:09 CEST | Press release
Bentley Systems’ Acceleration Fund Announces the Launch of Virtuosity, a Bentley Company
MA-BLUECONIC9.7.2020 15:07:09 CEST | Press release
BlueConic Expands Customer Lifecycle Orchestration Capabilities
IFPMA9.7.2020 15:02:08 CEST | Press release
New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom